Treatment
Treatment of hepatic encephalopathy is based on four simple principles:
Identification and Treatment or Precipitating Factors. lists several important factors that may precipitate or severely aggravate hepatic encephalopathy in patients with severe liver disease. Gastrointestinal bleeding and increased protein intake may provide increased substrate for the bacterial or metabolic formation of nitrogenous compounds that induce encephalopathy. In patients prone to develop hepatic encephalopathy there is a markedly increased sensitivity to central nervous system-depressant drugs, and their use should be avoided in these patients.
Reduction and Elimination of Substrate for the Generation or Nitrogenous Compounds, (a) Dietary protein restriction. Patients in coma should receive no protein, whereas those with mild encephalopathy may benefit from restriction of protein intake to 40 to 60 grams per day. Vegetable protein diets also appear to be less encephalopathogenic. (b) Bowel cleansing. This is important mainly in patients with encephalopathy precipitated by gastrointestinal bleeding or constipation, and is achieved by administration of enemas.
Reduction of Colonic Bacteria. Neomycin administered orally reduces the number of bacteria that are responsible for production of ammonia and other nitrogenous compounds.
Prevention of Ammonia Diffusion from the Bowel. This is achieved by administration of lactulose, a nonabsorbable disaccharide, which, when fermented to organic acids by colonic bacteria, leads to a lower stool pH. This lowered pH traps ammonia in the colon as nondiffusible NH4~ ions, but other mechanisms such as inhibition of bacterial ammonia production may also be important.
- ATHEROSCLEROSIS
- Initial Assessment
- ATRIAL RHYTHM DISTURBANCES
- PRINCIPLES OF CARDIOPULMONARY RESUSCITATION
- PHYSIOLOGY OF THE CORONARY CIRCULATION
- GENERAL SURGERY IN THE PATIENT WITH HEART DISEASE
- Differential Diagnosis and Evaluation of the Patient
- HYPERKINETIC PULMONARY HYPERTENSION
- Blood Chemistries
- PRE-EXCITATIOIi SYNDROMES
- THE ZOLLINGER-ELLISON SYNDROME
- BROliCHIECTASIS
- PROGNOSIS
- DISORDERS ASSOCIATED WITH MALABSORPTION
- DC CARDIOVERSION AND DEFIBRILLATION
- EMBOLIC DISEASE
- Medicaid Reform Project
- CLINICAL APPROACH TO LIVER DISEASE
- VARIATiT ANGINA
- Pulmonary Vasculitis
- CLINICAL PRESENTATION
- ADAPTATION TO NEPHRON LOSS
- Liddle’s Syndrome
- Hypersensitivity Pneumonitis
- Miscellaneous
- DISEASES OF THE ESOPHAGUS
- LABORATORY TESTS TOR BILIRUBIN
- DRUG-ASSOCIATED RENAL INJURY
- Proteinuria
- Potassium Homeostasis
- CARDIOVASCULAR PHYSIOLOGY DURING PREGNANCY - ELECTROPHYSIOLOGY
- POLYPS OF THE GASTROINTESTINAL TRACT
- BILIRUBIN METABOLISM
- Urinary Tract Obstruction
- CYSTIC FIBROSIS